A new predictor of coronary no-reflow phenomenon after percutaneous coronary intervention in saphenous vein grafts: Eisonophil

Deniz Elcik; Mustafa Fehmi Bireciklioglu; Aydin Tuncay

doi:10.5455/JMRR.20240322020054

Abstract
Introduction: Coronary no-reflow phenomenon is an important factor that causes increased mortality and morbidity in percutaneous coronary intervention procedures. How this happened is a subject that is still under investigation and has no clear answer. In this study, we examined the effect of eosinophil values in coronary no-reflow.
Methods: The study was designed retrospectively. Four hundred four patients who underwent coronary bypass were included in the study; 153 in the no-reflow group and 251 in the regular coronary flow group. The relationship between eosinophil values and no-reflow was examined.
Results: In the examination between no-reflow and eosinophil, there was a significant difference between the groups (p <0.001), Multivariate analysis showed that presence of coronary stent (p = 0.001), diabetes mellitus (P = 0.001), neutrophils (P = 0.001), eosinophil (P = 0.001) were effective coronary no-reflow phenomena.
Conclusions: Many factors play a role in developing no-reflow and eosinophil height among these factors. It should be kept in mind that no-reflow may develop if eosinophil elevation is present in coronary artery disease.

Key words: Coronary artery disease, eosinophil, no-reflow phenomenon, saphenous vein grafts